263
Views
12
CrossRef citations to date
0
Altmetric
Research Articles

Ellagic acid alleviates clozapine‑induced oxidative stress and mitochondrial dysfunction in cardiomyocytes

, , , & ORCID Icon
Pages 1625-1633 | Received 22 Sep 2020, Accepted 08 Nov 2020, Published online: 22 Nov 2020

References

  • Abdel-Wahab, B.A., Abdalla, M.E., and El-Khawanki, M.M., 2014a. Does clozapine induce myocarditis, myocardial oxidative stress and DNA damage in rats? Egyptian Journal of Forensic Sciences, 4 (3), 75–82.
  • Abdel-Wahab, B.A. and Metwally, M.E., 2015. Clozapine-induced cardiotoxicity: role of oxidative stress, tumour necrosis factor alpha and NF-κβ. Cardiovascular Toxicology, 15 (4), 355–365.
  • Abdel-Wahab, B.A., et al., 2014b. Protective effect of captopril against clozapine-induced myocarditis in rats: role of oxidative stress, proinflammatory cytokines and DNA damage. Chemico-Biological Interactions, 216, 43–52.
  • Baeeri, M., et al., 2017. Molecular evidence on the protective effect of ellagic acid on phosalone-induced senescence in rat embryonic fibroblast cells. Food and Chemical Toxicology : An International Journal Published for the British Industrial Biological Research Association, 100, 8–23.
  • Beach, D.C. and Giroux, E., 1992. Inhibition of lipid peroxidation promoted by iron(III) and ascorbate. Archives of Biochemistry and Biophysics, 297 (2), 258–264.
  • Cao, Y.-Y., et al., 2015. Exenatide reduces tumor necrosis factor-α-induced apoptosis in cardiomyocytes by alleviating mitochondrial dysfunction. Chinese Medical Journal, 128 (23), 3211–3218.
  • Contreras-Shannon, V., et al., 2013. Clozapine-induced mitochondria alterations and inflammation in brain and insulin-responsive cells. PLoS One, 8 (3), e59012.
  • Curto, M., et al., 2016. Systematic review of clozapine cardiotoxicity. Current Psychiatry Reports, 18 (7), 68.
  • Dawson, J.L., et al., 2018. Is the higher incidence of clozapine induced myocarditis in Australia due to awareness and monitoring? Schizophrenia Research, 201, 426–427.
  • Deus, C.M., et al., 2020. Mitochondria-lysosome crosstalk: from physiology to neurodegeneration. Trends in Molecular Medicine, 26 (1), 71–88.
  • Dianat, M., et al., 2015. Ellagic acid improved arrhythmias induced by CaCL2 in the rat stress model. Avicenna Journal of Phytomedicine, 5, 120.
  • Eno, C.O., et al., 2013. Noxa couples lysosomal membrane permeabilization and apoptosis during oxidative stress. Free Radical Biology & Medicine, 65, 26–37.
  • Fehsel, K., et al., 2005. Clozapine induces oxidative stress and proapoptotic gene expression in neutrophils of schizophrenic patients. Journal of Clinical Psychopharmacology, 25, 419–426.
  • Galano, A., Francisco Marquez, M., and Pérez-González, A., 2014. Ellagic acid: an unusually versatile protector against oxidative stress. Chemical Research in Toxicology, 27 (5), 904–918.
  • Gioda, C.R., et al., 2010. Cardiac oxidative stress is involved in heart failure induced by thiamine deprivation in rats. American Journal of Physiology. Heart and Circulatory Physiology, 298 (6), H2039–H2045.
  • Hassoun, E.A., Vodhanel, J., and Abushaban, A., 2004. The modulatory effects of ellagic acid and vitamin E succinate on TCDD-induced oxidative stress in different brain regions of rats after subchronic exposure. Journal of Biochemical and Molecular Toxicology, 18 (4), 196–203.
  • Hemmati, A., et al., 2018. Ellagic acid protects against arsenic trioxide–induced cardiotoxicity in rat. Human & Experimental Toxicology, 37, 412–419.
  • Hissin, P.J. and Hilf, R., 1976. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Analytical Biochemistry, 74 (1), 214–226.
  • Huang, P., et al., 2017. Phenylarsine oxide (PAO) induces apoptosis in HepG2 cells via ROS-mediated mitochondria and ER-stress dependent signaling pathways. Metallomics : Integrated Biometal Science, 9 (12), 1756–1764.
  • Khalid, M., et al., 2019. Clozapine-induced cardiotoxicity presenting as sepsis: a case report and literature review. Case Reports in Medicine, 2019, 1–6.
  • Khokhar, J.Y., et al., 2018. Unique effects of clozapine: a pharmacological perspective. Advances in Pharmacology. New York, NY: Elsevier.
  • Layland, J.J., Liew, D., and Prior, D.L., 2009. Clozapine‐induced cardiotoxicity: a clinical update. The Medical Journal of Australia, 190 (4), 190–192.
  • Lin, M.-C. and Yin, M.-C., 2013. Preventive effects of ellagic acid against doxorubicin-induced cardio-toxicity in mice. Cardiovascular Toxicology, 13 (3), 185–193.
  • Martín-Fernández, B. and Gredilla, R., 2016. Mitochondria and oxidative stress in heart aging. Age (Dordrecht, Netherlands), 38 (4), 225–238.
  • Mishra, S. and Vinayak, M., 2014. Ellagic acid inhibits PKC signaling by improving antioxidant defense system in murine T cell lymphoma. Molecular Biology Reports, 41 (7), 4187–4197.
  • Mottola, F., et al., 2020. Protective activity of ellagic acid in counteract oxidative stress damage in zebrafish embryonic development. Ecotoxicology and Environmental Safety, 197, 110642.
  • Naserzadeh, P., et al., 2018. Curcumin protects mitochondria and cardiomyocytes from oxidative damage and apoptosis induced by hemiscorpius lepturus venom. Drug Research, 68, 113–120.
  • Nigam, P., 2007. Biochemical markers of myocardial injury. Indian Journal of Clinical Biochemistry, 22 (1), 10–17.
  • Nippert, F., Schreckenberg, R., and Schlüter, K.-D., 2017. Isolation and cultivation of adult rat cardiomyocytes. JoVE (Journal of Visualized Experiments), 128, e56634.
  • Priyadarsini, K.I., et al., 2002. Free radical studies of ellagic acid, a natural phenolic antioxidant. Journal of Agricultural and Food Chemistry, 50 (7), 2200–2206.
  • Ratnam, D.V., et al., 2006. Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective. Journal of Controlled Release: Official Journal of the Controlled Release Society, 113 (3), 189–207.
  • Ríos, J.-L., et al., 2018. A pharmacological update of ellagic acid. Planta Medica, 84 (15), 1068–1093.
  • Ronaldson, K.J., Fitzgerald, P.B., and McNeil, J.J., 2015. Clozapine‐induced myocarditis, a widely overlooked adverse reaction. Acta Psychiatrica Scandinavica, 132 (4), 231–240.
  • Ronaldson, K.J., 2017. Cardiovascular disease in clozapine-treated patients: evidence, mechanisms and management. CNS Drugs, 31 (9), 777–795.
  • Salimi, A., et al., 2016. Selective anticancer activity of acacetin against chronic lymphocytic leukemia using both in vivo and in vitro methods: key role of oxidative stress and cancerous mitochondria. Nutrition and Cancer, 68 (8), 1404–1416.
  • Scaduto, R.C., Jr. and Grotyohann, L.W., 1999. Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophysical Journal, 76 (1 Pt 1), 469–477.
  • Solaini, G. and Harris, D.A., 2005. Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. The Biochemical Journal, 390 (Pt 2), 377–394.
  • Valko, M., et al., 2007. Free radicals and antioxidants in normal physiological functions and human disease. The International Journal of Biochemistry & Cell Biology, 39 (1), 44–84.
  • Wang, J.-F., et al., 2008. Clozapine-induced myocarditis: role of catecholamines in a murine model. European Journal of Pharmacology, 592 (1–3), 123–127.
  • Wheeler, A., Humberstone, V., and Robinson, G., 2009. Outcomes for schizophrenia patients with clozapine treatment: how good does it get? Journal of Psychopharmacology, 23 (8), 957–965.
  • Williams, D.P., et al., 2003. Bioactivation of clozapine by murine cardiac tissue in vivo and in vitro. Chemical Research in Toxicology, 16 (10), 1359–1364.
  • Xu, Q., et al., 2007. Optimizing dosage of ketamine and xylazine in murine echocardiography. Clinical and Experimental Pharmacology & Physiology, 34 (5–6), 499–507.
  • Youssef, D.L., Narayanan, P., and Gill, N., 2016. Incidence and risk factors for clozapine-induced myocarditis and cardiomyopathy at a regional mental health service in Australia. Australasian Psychiatry, 24 (2), 176–180.
  • Yu, Y.-M., et al., 2005. Reduction of oxidative stress and apoptosis in hyperlipidemic rabbits by ellagic acid. The Journal of Nutritional Biochemistry, 16 (11), 675–681.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.